Healthcare Market | Grand View Research

Monday, 1 February 2016

Liver Diseases Therapeutics Market Forecast, Industry Outlook, Market Demand, Share 2015 To 2022

The global liver diseases therapeutics market is expected to reach USD 12.1 billion by 2022, according to a new report by Grand View Research Inc. The changing lifestyle habits including increasing alcohol consumption is a vital driving force of this market.
The changing dynamics in healthcare sector has heightened the importance of patients and practitioners treatment decision, which suggests that liver diseases therapeutics market is expected to witness lucrative growth over the forecast period.
Furthermore, the growing global base of geriatric population is likely to expand patient base. However, slow adoption rate of liver diseases therapeutics due to lack of clinical evidences and awareness is expected to serve as a key challenge for manufacturers. However, the incorporation of regulatory agencies along with favorable government initiatives and support will help improve usage rates.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/liver-disease-therapeutics-market

North America liver diseases therapeutics market, by product, 2012-2022, (USD Million)

Further key findings from the report suggest:

Antiviral drugs segment is expected to generate over 40.0% of the total revenue by 2022 due to the potential commercialization of GS-7977 in 2015. Moreover, the ability of this class to render safe and efficient treatment will drive segment growth over the forecast period.
The demand for vaccines is expected to grow at a lucrative rate of over 20.0% over the forecast period. Key factors responsible for the growth of this market include consideration of vaccines as a preventive treatment alternative for liver diseases. Increasing government initiatives towards vaccination programs for liver diseases is expected to further boost market growth
In 2014, North America dominated the market in terms of revenue owing to the availability of FDA-approved treatment options for liver diseases coupled with the presence of an extensive number of clinical trial studies and new product development.
Asia Pacific is expected to witness the fastest growth of over 8.5% over the forecast period. This growth is attributed to the wide presence of untapped needs, rising expenditure levels, and the introduction of favorable government initiatives
Some key players of this market include Abbott Laboratories, Astellas Pharma Inc., Bristol-Mayers Squibb, Gilead Sciences, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Sanofi S.A., Pfizer Inc., Takeda Pharmaceuticals, Valeant Pharmaceuticals, and Watson Pharmaceuticals
Market participants are constantly engaged in developing clinical evidences in an attempt to improve presence, ensure sustainability, develop cost effective drug, and avoid barriers such as product recalls

Browse All Reports of this category @ http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global liver diseases therapeutics market on the basis of product and region:
Liver Diseases Therapeutics Product Outlook (Revenue, USD Million, 2012 – 2022)

Antiviral Drugs
Vaccines
Chemotherapy
Targeted Therapy
Immunosuppressants
Immunoglobulins
Corticosteroids

Liver Diseases Therapeutics Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America
Europe
Asia Pacific
RoW

Transfection Reagent & Equipment Market Hits $1.09 Billion By 2022: Grand View Research, Inc.

The global transfection reagent & equipment market is expected to reach USD 1,086.02 million by 2022, according to a new report by Grand View Research, Inc. This anticipated growth in demand can be attributed to growing need for protein production, biopharmaceutical development, and vaccine research and development; all of which rely heavily on cytological R&D and transfection.
Larger market entities are also involved in efforts to expand their market presence in the Asia Pacific region and tap the high potential for growth available. Expected growth of genomic and proteomic research is also a strong factor which will positively impact the growth in demand for transfection.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/transfection-reagents-and-equipment-market

U.S. Transfection Reagent & Equipment Market revenue by method, 2012-2022, (USD Million)

Further key findings from the study suggest:

Out of both the broad segments of products available, transfection equipment accounted for a larger share of the market in 2014 and owing to their inherently more expensive nature than reagents are expected to maintain this dominant position over the forecast period.
The market space for transfection has an abundant number of methods to achieve the aforementioned. However, these vary significantly in usage rates and implementation complexities. Electroporation and liposomal transfection combine to account for over 30% of the market owing to high associated advantages.
Growing applications of transfection techniques poise the segments in a strong position and estimated valuation clocks usage of transfection in gene expression at over USD 130 million and for protein production at over USD 110 million for the year 2014.
North America was observed to be responsible for the largest share of revenue in 2014 which amounted to a little over USD 240 million. The United States houses the headquarters of operations for a number of market leaders and a number of established research and development. This provides a strong platform for development, manufacture & distribution various vaccines, and biopharmaceuticals which fuels market growth.
However, it is Asia Pacific region which is anticipated to witness significant growth over the forecast period in various segments owing to considerable growth of cytological research, development of biosimilar drugs and high potential of growth in these relatively untapped regional segments.
Asia Pacific is expected to grow at a significant rate over the forecast period in terms of increasing production and development of vaccines, drugs, and new biologics. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in biopharmaceutical manufacturing and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.
Promega, Roche and Thermo Fisher owned Life Technologies accounted for the largest of revenue in 2014 and are involved in new product development for expansion of their portfolios over the forecast period. Acquisition of smaller players is also expected over the forecast period by larger companies
Key market players in the Transfection Reagent & Equipment Market include BTX (Harvards Apparatus Inc.), SignaGen Laboratories, OriGene Technologies, EMD Millipore, VWR International LLC, Bio-Rad Laboratories Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza AG, Life Technologies (Thermo Fisher), and Promega Corporation.

Browse All Reports of this category @ http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented Transfection Reagent & Equipment Market on the basis of product, method, application, and region:

Global Transfection reagents & equipment Product Outlook (Revenue, USD Million, 2012 – 2022)

Reagents
Equipment

Global Transfection reagents & equipment Method Outlook (Revenue, USD Million, 2012 – 2022)

Electroporation
Liposomes
Particle Bombardment
Microinjection
Adenoviral vectors
Direct microinjection
Calcium phosphate
DEAE-dextran
Magnetic beads
Activated Dendrimers
Laserfection

Global Transfection reagents & equipment Application Outlook (Revenue, USD Million, 2012 – 2022)

Gene expression studies
Protein production
Transgenic delivery
Cancer research
Biomedical research

Transfection reagents & equipment Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America

U.S.
Canada

Europe

Germany
UK

Asia Pacific

Japan
China

Latin America

Brazil

South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Website: Grand View Research

Blog Site: http://www.divog.org/

Portable X-Ray and CT Scan Devices Market Growth, Trends, Segment To 2020

The global market for portable X-ray and CT scan devices is expected to reach USD 8,408.0 million by 2020, according to a new study by Grand View Research, Inc. Rising demand for bedside imaging, home healthcare and the growing use of CT scan devices for anatomical confirmation and to assess the accuracy of medical implants during and post interventional medical procedures are two of the most significant growth drivers of this market.

The market will also be driven by factors such as rising prevalence of target diseases such as cardiovascular, dental and orthopedic disorders and cancer, growing global base of geriatric population and the consequent rise in the number of medical procedures especially the ones involving medical implants.

The presence of high growth opportunities in emerging Asian and Latin American countries and the introduction of technologically advanced and cost effective products catering to the cost sensitive clientele present in the aforementioned regions will fuel the future growth of this market. Moreover, the implementation of government initiatives such as the 12th Five Year Plan in China will ease the entrance of market players into these regions and capitalize on the untapped growth opportunities.

The global portable X-ray devices market was dominated by the mobile X-ray devices market on account of the rising demand for bedside imaging and point of care diagnostics. In addition, the fact that these devices eliminate the need for multiple radiology departments in a healthcare institution and therefore prove to be cost effective serves this market as a driver. However, high maneuverability associated with handheld X-ray devices and the introduction of products such as the NOMAD Pro will help the global handheld X-ray devices market exhibit the highest CAGR during the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/portable-x-ray-and-ct-scan-devices-industry

Portable X-ray devices market revenue share by products, 2012

Further Key findings from the study suggest:

The global portable X-ray and CT scan devices market was valued at USD 4,677.0 million in 2012 and is expected to grow at a CAGR of 7.6% from 2013 to 2020
The global portable CT scan devices market was dominated by the medium slice scanners (64 slices) market owing to their high usage rates and high image resolution capabilities. Its market share was calculated at above 60% in 2012.
Digital radiography (DR) is identified as the fastest growing technology in the overall portable X-ray devices market. Rising demand of PACS (Picture Archiving and Communication Systems) based radiology devices and growing demand for filmless X-ray devices are some of the factors accounting for the aforementioned inference.
North America is expected to dominate the overall market throughout the forecast period owing to the presence of sophisticated healthcare infrastructure, reimbursement framework and high healthcare expenditures in this region. However, the presence of high unmet medical needs in emerging Asian economies such as India and China will help the Asia-Pacific portable X-ray and CT scan devices market grow at the highest CAGR (10.2% from 2013 to 2020).The portable X-ray and CT scan devices market is highly competitive with players such as GE Healthcare, Philips Healthcare, Siemens Healthcare, Hitachi Medical Systems and Varian Medical Systems dominating the market. However, technological innovations play an integral role in the market and manufacturers are developing strategies in congruence with this to ensure sustainability and gain market share. E.g. The launch of handheld X-ray device – “NOMAD Pro” by Aribex Inc.

Browse All Reports of this category @ http://www.grandviewresearch.com/industry/healthcare

For the purpose of this study, Grand View Research has segmented the global portable X-ray and CT scan devices market on the basis of product, technology and region:

Portable X-ray and CT Scan Devices Product Outlook

X-Ray Devices
Mobile X-Ray Devices
Handheld X-Ray Devices
CT Scan Devices

Portable X-ray and CT Scan Devices Technology Outlook

X-Ray Devices
Analog
Computed Radiography
Digital Radiography
CT Scan Devices
Low Slice Scanners
Medium Slice Scanners
High Slice Scanners

Portable X-ray and CT Scan Devices Regional Outlook

North America
Europe
Asia-Pacific
RoW